Serum concentrations of CXCL1 and CXCL5 in myeloma patients were below the concentrations used in our in vitro studies (186.5 ± 129.1 pg/ml and 765 572.1 pg/ml, respectively [57]). The gene discussed is CXCL1; the disease is plasma cell myeloma.